eli lilly retatrutide trial results infiltrates anti-obesity market as Phase III for begins Lilly's triple agonist achieves 16.8%

This is exactly the kind of real-world data we should be collecting

This disorder arises from impaired lymphatic drainage due to either congenital abnormalities (primary lymphedema) or acquired damage to the lymphatic system (secondary lymphedema)

Additionally, liver function parameters can improve in patients with fatty liver disease, indicating improved metabolic health

Anecdotally, Ive lost about 24 pounds so far in the Triumph-1 trial and my running speed and efficiency has noticeably gone up

A GLP-1 supplement (also searched as "GLP 1 supplement") is any over-the-counter dietary supplement marketed in connection with GLP-1 (glucagon-like peptide-1), the appetite-regulating hormone that prescription drugs like semaglutide and tirzepatide mimic

It's also being studied for fatty liver disease (NASH) and cardiovascular outcomes